Tissuefactor pathway inhibitor-2 inhibits epithelial-mesenchymal transition in human prostate cancer cells

刘树瀚,宣强,谈宜傲,吴本鹤,孙凌峰,乔龙标,翟路路,孙友文,周林玉
DOI: https://doi.org/10.19405/j.cnki.issn1000-1492.2015.12.007
2015-01-01
Abstract:Objective To investigate the influence of tissue factor pathway inhibitor-2 ( TFPI-2 ) on epithelial-mes-enchymal transition (EMT) in human prostate cancer cells. Methods PC3M cells were cultured and divided into three groups, respectively transfected with TFPI-2 gene eukaryotic expression vector, empty carrier and nothing. Wound healing assay and thanswell assay were performed to evaluate motility and invasive capacity of three groups PC3M cells. Then the three groups cells were dealt with by transforming growth factor-β1 (TGF-β1), cellular mor-phology was observed with inverted phase contrast microscope. Protein and mRNA levels of characteristic markers ( E-cadherin, vimentin and snail) involved in EMT were respectively detected in cells of three groups by Western blot and reverse transcription polymerase chain reaction ( RT-PCR) . Results were statistically analyzed. Results Wound healing assay and thanswell assay revealed that migration rate of transfected cells was lower ( P<0. 05 ) , in-vasive cells number of that was fewer (P<0. 05). Transfected cells displayed an epithelial-like morphology, trans-fected empty-carrier cells and non-transfected cells showed a mesenchymal-like morphology by inverted phase con-trast microscope. Western blot and RT-PCR displayed that E-cadherin was more, vimentin and snail were less on protein and mRNA levels in transfected cells compared with transfected empty-carrier cells and non-transfected cells;the difference was statistically significant ( P<0. 05 ) , and the difference between transfected empty-carrier cells and non-transfected cells was not statistically significant . Conclusion TFPI-2 can inhibit EMT in human prostate cancer cells. It is one of the possible mechanisms of inhibiting the invasion and metastasis of prostate canc-er cell. It will help to provide new train of thought and direction for gene and biologically targeted theropy for pros-tate cancer.
What problem does this paper attempt to address?